Article
Myeloid neoplasms in individuals with breast and ovarian cancer and the association with deleterious germline variants.
Gynecologic oncology - 1 Aug 2024
Franco Stephanie, Godley Lucy A
Abstract excerpt
Historically, the increased incidence of myeloid neoplasms observed in individuals with breast and ovarian cancer has been attributed exclusively to prior exposure to cancer-directed therapies. However, as the association between deleterious germline variants and the development of hematopoietic malignancies (HMs) becomes better established, we propose the increased incidence of myeloid neoplasms in those with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
